An mRNA vaccine for influenza

Nature Biotechnology

Volumn 30, Issue 12, 2012, Pages 1202-1204

  Wong, Sook San ^a   Webby, Richard J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; DNA VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; MESSENGER RNA; MRNA VACCINE; RNA VACCINE; UNCLASSIFIED DRUG;

DENGUE; DRUG DESIGN; DRUG EFFICACY; DRUG MANUFACTURE; HUMAN; IMMUNOGENICITY; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; NONHUMAN; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RNA STABILITY; VIRUS STRAIN;

ANIMALS; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; RNA, MESSENGER;

EID: 84870890171     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2439     Document Type: Note

References (11)

1. Lothar, s. et al. Nat. Biotechnol. 30, 1210-1216 (2012).
2. Fiore, A.e., Bridges, C.B. & Cox, N.J. Curr. Top. Microbiol. Immunol. 333, 43-82 (2009).
3. Ulmer, J.B., Mason, P.w., Geall, A. & Mandl, C.w. Vaccine 30, 4414-4418 (2012).
4. Hoerr, i., Obst, R., Rammensee, H.G. & Jung, G. Eur. J. Immunol. 30, 1-7 (2000).
5. shinya, K. et al. Nature 440, 435-436 (2006).
6. Pearce, M.B., Belser, J.A., Houser, K.v., Katz, J.M. & Tumpey, T.M. Vaccine 29, 2887-2894 (2011).
7. Louz, D., Bergmans, H.E., Loos, B.P. & Hoeben, R.C. Crit. Rev. Microbiol. (2012).
8. Richardson, J.s., Dekker, J.D., Croyle, M.A. & Kobinger, G.P. Hum. Vaccin. 6, 439-449 (2010).
9. Dejnirattisai, W. et al. Science 328, 745-748 (2010).
10. Corti, D. et al. Science 333, 850-856 (2011).
11. ekiert, D.C. et al. Nature 489, 526-532 (2012).